1. Ecology.Chemistry. Biotechnology.

2. 65 Ulyanovyh Street, Ufa city. Tel. +7 (347) 242-49-53. Web-site: http://ecohimtech.ruhttp://ecohimtech.ru COMPANY HISTORY. The company was incorporated in 1991 in Ufa. In 2003-2004 production premises 1 000 sq.m in area were bought, in 2011 the Company purchased a land plot 0,8 ha. Since 1992 the Company has been carrying out research activities and developing technologies of antiparasitic medication production (Phenasal®, Azinox®,Carbendazim, Albendazol, etc.). In 1994 we launched production of Phenasal, and in 1996 - officinal production of Azinox. Since 2006 by order of the Healthcare Ministry of the Russian Federation the Company has been producing antimalaria drugs: Chinini sulfate and Primachinum diphosphate. LICENSES. License to carry out activities associated with drug production for veterinary use from 2013. License to carry out pharmaceutical activities, including wholesale and retail pharmaceutical trading from 2013. COMPANY OPERATING POLICY. Determination to leadership; Statutory compliance; Scientific and technologic innovations; Provision of decent living standards for the Company staff; Keeping sanitary and industrial safety. AWARDS. Diploma of Russian Academy of Medical Sciences Presidium for 2004 for a series of works “On Developing ”Highly Effective Anthelminthic Drugs”. Diploma of Ufa city administration for 2010 “Responsible Borrower” “City Weal” award winner, Ufa city, 2009.

3. PRODUCTION. RELEASED RANGE OF PRODUCTS. Probiotics from bacteria Bacillus subtilis 12B: 1) an alternative to antibiotics (derive up to 70antibiotic substances, effecting to nearly all species of pathogenic microorganisms, including mycobacteria tuberculosis, salmonellosis, shigellosis, brucellosis, etc.; 2) free from disadvantages of antibiotics: have no self- tapering action, keep normal biocoenose of the intestines, do not depress, but reinforce the immune system; 3) act as immunostimulators. SPOROVIT. Biostimulants: designed to accelerate processes of recovery and rehabilitation of the organism, have antiseptic and anti-inflammatory effect. NUKLEOPEPTID, MIKROVITAM. antiparasitic agents for human and animal use. PHENASAL, CARBENDAZIM, ALBENDAZOL, AZINOX.

4. BIOTECHNOLOGY MARKET In 2025, the world biotechnology market will reach the level of 2 trillion USD, growth rates in certain market segments vary from 5-7 to 30 % per year. Russian share at biotechnology market is nowadays less than 0,1 %. 100% feed amino acids, up to 80% feed ferments, 100% enzymes for household chemicals, over 50% of feed and veterinarian antibiotics, 100% lactic acid, from 50 to 100 % biotic food ingredients are imported to the Russian Federation. Production of world leading biotechnological companies has been represented at Russian market for 20 years, but none of those companies have organized its production in Russia. Biotechnology Development Program, which stipulates expansion of bioeconomic share of market to about 1% of the GDP to 2020, and to at least 3 % to 2030, has been carried out in the Russian Federation. Biotechnological product market in the Russian Federation, billion rubles Import-export ratio in consumption- production, % Product market in the Russian Federation for target groups of products amounts to 35 billions rubles, including 0,5 billion rubles in Bashkortostan republic.

5. PRODUCTION. PROJECTED ASSORTMENT UP TO 2020 PHARMACOPEIC LINE: Complex probiotic agents based on Bacillus subtilis Anthelminthic agents (Phenasal, Azinox/ Praziquantel) Antimalaria drugs (Chinini sulfate and Primachinum diphosphate) VETERINARIAN LINE: Feed additives for animals (stress-relieving, cartilage protectors, complex amino-acid addictives) Tissue specimen. FOOD LINE: Food ferments (diary,meat) TECHNOLOGY ROADMAPPING UP TO 2020. PHARMACOPEIC LINE: Pilot production. Pre-clinical, clinical trials according to pharmaceutical program. Certification, registration of medications. VETERINARIAN LINE: Pilot production. Trials according to veterinarian program. Certification, registration of agents as biologically active additives and veterinary drugs simultaneously. FOOD LINE: Pilot production. Certification as food products. GENERAL: Construction site selection. Investment feasibility study, design and survey work. Fund raising. Project implementation. Entrance to the market.

6. MARKETING Goals: To achieve leading positions in the market segment of probiotics, biostimulators, antiparasitic agents at the markets of the Volga Federal district and the Ural federal district up to 30 %, to gain market share all over the Russian Federation up to 2 % to 2020; To gain foreign market access; To introduce new production to the market: pharmacopeic and veterinarian medicatioons, food additives.

7. INVESTMENTS Investment program: 1. Establishment of a new production for 980 million rubles (Table 1); Table 1 Type of workTotal Pre-clinical, clinical trials90 Certification, registration, licensing10 Design and survey work80 Construction and installation operations, equipment800 Total980